Labshake search
Citations for Bio X Cell :
51 - 100 of 483 citations for 6 Bromo 3 4 dihydro 2H 1 benzopyran 3 methanamine since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2021Quote: ... C26 tumor-bearing mice received intraperitoneal injections with InVivoMAb anti-mouse IL-6 (1 mg in 200μl PBS; Bio X Cell, clone MP5-20F3). Body weight ...
-
bioRxiv - Pathology 2021Quote: ... IL-6 neutralizing antibody and IgG control (Bioxcell, BE0046 and BE0088). Rapamycin and Torin1 were purchased from LC Laboratories ...
-
bioRxiv - Immunology 2022Quote: ... and then transferred to a 96 well plate that had been coated overnight at 4°C with 5µg/ml αCD3 (BE0001-1, BioXcell), 5µg/ml CD80-Fc (555404 ...
-
bioRxiv - Immunology 2020Quote: ... LFA blocking antibody (M17/4; BioXCell) was administered i.p ...
-
bioRxiv - Cancer Biology 2020Quote: ... and anti-CTLA-4 (BioXCell, BE0164) or isotype control (MSD IgG1 control for muDX400 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and anti-CTLA-4 (BioXCell # BE0164) were diluted in PBS and dosed at 10 mg/kg every 3 days ...
-
bioRxiv - Cancer Biology 2020Quote: ... with 200 μg of ◻PD-L1 (10F.9G2) or αPD-1 (RMP1-14) or αCTLA-4 (9H10) antibody or with isotype control antibodies (all from BioXcell) on days 9 ...
-
bioRxiv - Cancer Biology 2021Quote: Mice were treated with either IgG (5 mg/kg as an anti-4-1BB control, 10 mg/kg as an anti-PD-1 control, BioXcell), anti-4-1BB agonist (5 mg/kg ...
-
bioRxiv - Immunology 2023Quote: ... Cells were washed in FACS buffer followed by surface staining for 30 min at 4°C with directly conjugated antibodies diluted in FACS buffer containing 1:100 anti-CD16/32 (Fc block; BioXCell) to block non-specific binding ...
-
bioRxiv - Immunology 2023Quote: ... LCMV-NP (self-conjugated to AF488 using Thermo Fisher AF488 labeling kit per manufacturer’s instructions, BioXcell, 1:50, clone VL-4).
-
bioRxiv - Immunology 2024Quote: ... and IL-4-reactive monoclonal antibodies for in vivo studies (IL-4 MAb) were purchased from BioXCell (BE0045). All TLR agonists were purchased from Invivogen ...
-
bioRxiv - Immunology 2022Quote: ... in the presence of 10μg/ml rIL-6 (R&D) and neutralizing antibodies to IL-2 (JES6-1A12 BioXcell, 5μg/ml and S4B6-1 BioXcell, 5μg/mL).
-
bioRxiv - Immunology 2019Quote: ... anti-IL-4 (BioXcell, 11B11, 10ug/mL), IL-12 (Peprotech ...
-
bioRxiv - Cancer Biology 2021Quote: ... and anti-4-1BB (clone LOB12.3, BioXCell) treatment ...
-
bioRxiv - Immunology 2022Quote: ... and 3μg/mL anti–IL-4 (BioXcell) were used ...
-
bioRxiv - Immunology 2023Quote: Studies of anti-CTLA-4 (BE0032, BioXcell) therapy in mice bearing CT26 and B16 tumors ...
-
bioRxiv - Immunology 2022Quote: ... Inhibition of CTLA-4 signaling was performed by intraperitoneal injection of 500μg/dose of αCTLA-4 (clone: UC10-4F10-11, BioXcell) supplemented with 1mg/dose of IgG2b isotype (clone ...
-
bioRxiv - Immunology 2019Quote: ... For Th2 induction 1×105 naïve T cells were cultured for 4 days with plate-bound αCD3ε (10 μg mL−1, clone 145-2C11; Bio X Cell) and αCD28 (10 μg mL−1 ...
-
bioRxiv - Immunology 2019Quote: ... 2 to 3×105 naïve T cells were cultured for 4 days with plate-bound αCD3ε (10 μg mL−1, clone 145-2C11; Bio X Cell), αCD28 (1 μg/mL ...
-
bioRxiv - Cancer Biology 2023Quote: ... were injected intraperitoneally with monoclonal antibodies against PD-1 (RMP1-14, 250 μg per dose) and CLTA-4 (9D9, 100 μg per dose) (BioXCell, Lebanon, NH) in sterile PBS or a control PBS solution (25) ...
-
bioRxiv - Immunology 2020Quote: ... and anti-IL-4 (10 µg/ml, BioXCell). Th1 cells were then cultured ...
-
bioRxiv - Immunology 2022Quote: ... anti-CTLA-4 (clone: UC10-4F10-11, BioXcell) or isotype control antibodies (clone ...
-
bioRxiv - Immunology 2023Quote: ... and anti-IL-4 antibody (clone 11B11, BioXCell) at a concentration of 10 µg/ml ...
-
bioRxiv - Immunology 2023Quote: ... and anti-IL-4 Ab (clone 11B11, BioXCell) at a concentration of 10 µg/ml ...
-
bioRxiv - Immunology 2021Quote: ... – and in vivo ICI treatment – anti-mouse PD-1 (RMP1-14) and anti-mouse CTLA-4 (9D9) – were purchased from Bio X Cell (USA). For T cell depletion ...
-
bioRxiv - Immunology 2022Quote: ... NK cells of C57BL/6 mice were deleted by intraperitoneal injection of anti-NK1.1 (BioXcell) antibodies on day -2 (200 μg/each) ...
-
bioRxiv - Cancer Biology 2022Quote: ... mice were treated with 200 μg anti-mouse IL-6 (MP5-20F3, Bio X Cell) once on alternate days and/or 10 μg anti-mouse G-CSF (67604 ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 200 µg of anti-CTLA-4 (BioXCell BE0164), or 400 µg of anti-IgG2b isotype control (BioXCell BE0090) ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 200 μg anti-CTLA-4 (clone 9H10, BioXcell), or their respective IgG controls ...
-
bioRxiv - Immunology 2022Quote: ... anti–mIL-4 (8 μg/mL, Bio X Cell), and anti–mIFN-γ (8 μg/mL ...
-
bioRxiv - Immunology 2021Quote: ... anti–mIL-4 (8 μg/mL, Bio X Cell), and anti–mIFN-γ (8 μg/mL ...
-
bioRxiv - Immunology 2020Quote: ... and anti-IL-4 (clone 11B11, Bio X Cell). Briefly ...
-
bioRxiv - Immunology 2022Quote: ... 15 and αCTLA-4 (9H10; BioXcell; 200 μg/dose) on days 0 ...
-
bioRxiv - Cancer Biology 2024Quote: ... anti-4-1BB (clone LOB12.3, Bio X Cell #BP0169), anti-PD-1 (clone 29F.1A12 ...
-
bioRxiv - Immunology 2021Quote: ... The following antibodies were used for in vivo blocking experiments: anti-LFA-1α (M17/4) and anti-Mac-1 (M1/70) (both from Bio X Cell, West Lebanon, NH). The following antibodies or reagents were used for in vivo cell depletion ...
-
bioRxiv - Cancer Biology 2020Quote: ... mice were treated with anti-IL-6 antibodies (20mg/kg, MP5-20F3 clone, BioXCell, NH, USA) or IgG control antibodies (20mg/kg ...
-
bioRxiv - Immunology 2021Quote: ... and CTLA-4 blocking antibody (clone 9D9, BioXCell, cat. BE0164) were administered either in combination or as single agents at 100ug/antibody/mouse every third day starting on the day of doxycycline diet addition for four total doses.
-
bioRxiv - Microbiology 2020Quote: ... and 25 μg of anti-IL-4 (BioXcell, clone 11B11) were complexed prior to intraperitoneally injection into mice ...
-
bioRxiv - Cancer Biology 2019Quote: ... mice were randomized and treated with αCTLA-4 (BioXCell, BP0164) or isotype control (BioXcell ...
-
bioRxiv - Cancer Biology 2021Quote: ... anti-4-1BB agonist (5 mg/kg, clone: 3H3, BioXcell), or anti-PD-1 (10 mg/kg ...
-
bioRxiv - Immunology 2021Quote: ... TREG conditions: anti–IL-4 (10 μg/mL, BioXCell, #BE0045), anti-IFN-γ (10 μg/mL ...
-
bioRxiv - Immunology 2022Quote: ... and 10 μg/mL a-IL-4 (clone 11B11, BioXCell). For Th17 conditions ...
-
bioRxiv - Immunology 2023Quote: ... Tumor-bearing mice were treated with anti-CTLA-4 (BioXCell) (n=8 ...
-
bioRxiv - Cancer Biology 2024Quote: ... and anti-CTLA-4 (clone 9D9, Bio X Cell, #BE0164) were performed as part of this study ...
-
bioRxiv - Pathology 2021Quote: ... Intraperitoneal injection was done with 200 ug of αIL-6 antibody or control rat IgG antibody (Bioxcell) three times per week as previously described (57) ...
-
bioRxiv - Physiology 2023Quote: ... Cells were treated with 10 μg/ml IgG control or IgG N-IL-6 (Bio X Cell), Wnt3a 200 ng/ml (Peprotech ...
-
bioRxiv - Immunology 2021Quote: ... plus 2 µg/mL anti-IL-4 antibody (BioXcell, Clone: 11B11); Th17 ...
-
bioRxiv - Immunology 2019Quote: ... complexed to 25 μg anti-IL-4 antibody (clone 11B11; BioXcell) in 100 μL sterile Phosphate buffered saline (PBS ...
-
bioRxiv - Immunology 2023Quote: ... In some studies 100µg anti-LFA-1α (clone M17/4, BioXcell), 100µg rat IgG2a isotype control (BioXcell) ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 200 ug anti-CTLA-4 (BioXcell, catalog #BE0164, clone 9D9) at days 9 and 12 after organoid implantation ...